Skip to main contentSkip to navigation
Sirius Investors
Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc.

RETA
NASDAQHealthcare

Insider Trading for RETA

View recent insider trading activity including purchases, sales, and awards. Insider trading can provide insights into how executives view their company's prospects.

Insider Trading Summary

Shares Acquired
Sign in to see amounts
Shares Disposed
Sign in to see amounts
Net Position
Sign in to see net activity
Unlock for free

Already registered? Sign in

Recent Activity (30 Days)

No insider transactions in the past 30 days.

Quarterly Activity (3 Months)

No insider transactions in the past 3 months.

Key Insider Activity: Sep 26, 2023 to Sep 26, 2023

Soni Manmeet Singh
ExecutiveChief Financial Officer
-582.1K shares
8 transactions
Meyer Colin John
ExecutiveCorporate Officer
-565.9K shares
9 transactions
ROSE WILLIAM
DirectorDirector
-223.5K shares
10 transactions
Huff James Warren
ExecutiveCorporate Officer
-994.7K shares
10 transactions
WORTLEY MICHAEL D
ExecutiveCorporate Officer
-364.3K shares
8 transactions

Transaction Details

DateInsiderRoleTransactionSharesPriceValueOwned AfterSEC Filing
Sep 26, 2023Desai Antal RohitDDirector, 10 Percent Owner: D-Return993.9K$0.00$0.000View
Sep 26, 2023Desai Antal RohitDDirector, 10 Percent Owner: D-Return134$172.50$23,115.000View
Sep 26, 2023McGaughy R Kent JrDDirector, 10 Percent Owner: D-Return2.8K$22.57$62,586.610View
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Sep 26, 2023
Locked
Click "View" in the SEC Filing column to access the detailed SEC form submission for each transaction.

Executive Activity:

Executives have been net sellers of RETA stock, though this may be part of planned diversification.